Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01ICU
|
||||
| Former ID |
DNAP001333
|
||||
| Drug Name |
Conjugated estrogens b
|
||||
| Synonyms |
Enjuvia (TN)
|
||||
| Indication | Hormone replacement therapy [ICD9: V07.4; ICD10:Z79.890] | Approved | [551871] | ||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Modulator | [533439], [536361] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
| Ref 533439 | Effect of MK-486 alone on Parkinsonism; studies on the clinical symptoms and catecholamine concentrations in the blood, urine and cerebrospinal fluid. No To Shinkei. 1977 Feb;29(2):205-13. | ||||
| Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.